Dianthus Therapeutics, Inc.
DNTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001690585
In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.40B in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Dianthus Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 103 | 140 | +37 |
| Shares | 39.1M | 46.8M | +7.72M (+19.7%) |
| Value | $728.6M | $1.84B | +$1.11B (+152.9%) |
New holders (51)
Institutions that held Dianthus Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (14)
Institutions that held Dianthus Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Deep Track Capital, LP | 2,233,148 | $41.6M |
| Hudson Bay Capital Management LP | 115,425 | $2.15M |
| ExodusPoint Capital Management, LP | 75,079 | $1.40M |
| Cubist Systematic Strategies, LLC | 43,381 | $808.2K |
| Squarepoint Ops LLC | 30,709 | $572.1K |
| Paloma Partners Management Co | 29,214 | $544.3K |
| XTX Topco Ltd | 27,003 | $503.1K |
| Verition Fund Management LLC | 22,945 | $427.5K |
| Intech Investment Management LLC | 12,969 | $241.6K |
| Aquatic Capital Management LLC | 3,187 | $59.4K |
| Caitong International Asset Management Co., Ltd | 356 | $6.63K |
| Quarry LP | 137 | $2.55K |
| IFP Advisors, Inc | 0 | $1.94K |
| Riggs Asset Managment Co. Inc. | 35 | $653 |